Top compounds associated with response to NT5C


Feature Type Standardized
Nominal ANOVA
mRNA JW-7-52-1 GDSC1000 pan-cancer AAC -0.087 0.09
mRNA Irinotecan CCLE pan-cancer AAC 0.089 0.09
mRNA AZD-2281 CTRPv2 pan-cancer AAC -0.059 0.09
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.06 0.09
mRNA NSC23766 CTRPv2 pan-cancer AAC -0.059 0.09
mRNA tacedinaline CTRPv2 pan-cancer AAC -0.063 0.09
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.059 0.09
mRNA MG-132 GDSC1000 pan-cancer AAC -0.081 0.09
mRNA dacarbazine CTRPv2 pan-cancer AAC 0.053 0.1
mRNA Nutlin-3a (-) GDSC1000 pan-cancer AAC 0.056 0.1
Download CSV